Avidity of IgG for rubella: an evaluation of the need for implementation at the Materno-Infantil Presidente Vargas Hospital in Porto Alegre, Rio Grande do Sul, Brazil
AUTOR(ES)
Reis, M.M., Tessaro, M.M., Cruz e Silva, J., Giordano, S. A., d'Azevedo, P.A.
FONTE
Brazilian Journal of Infectious Diseases
DATA DE PUBLICAÇÃO
2004-06
RESUMO
Rubella serum assays performed in the laboratory of the Materno-Infantil Presidente Vargas Hospital (HMIPV) from 1998 to 2002 were reviewed to determine if IgG avidity assays should be implemented. IgG was determined using the Enzyme Linked Fluorescent Assay, ELFA, VIDAS® system, bioMérieux or the Microparticle Enzyme Immunoassay, MEIA, Axsym® system, Abbott, and IgM was determined using the ELFA, VIDAS® system, bioMérieux, a capture format assay. Specific IgG was assayed in 2,863 samples, with positive results for 84% of the patients, for the most part with high levels of antibodies. IgM was assayed in 2,851 samples, being positive in 14 (0.49%) and inconclusive in 25 (0.88%). Serology for toxoplasmosis was also positive or inconclusive in 5 patients. After a cost-effectiveness analysis, it was decided not to implement avidity assays, considering that the HMIPV is a public institution, with limited funding. Difficulties concerning the integration of the Clinical Pathology Service with the Clinical Staff of the institution were also considered.
Documentos Relacionados
- Fatores associados à saúde materno-infantil no Rio Grande do Sul, Brasil
- Airborne fungi in the city of Porto Alegre, Rio Grande do Sul, Brazil
- Mortalidade infantil evitável e fatores associados em Porto Alegre, Rio Grande do Sul, Brasil, 2000-2003
- Distribuição espacial do risco: modelagem da mortalidade infantil em Porto Alegre, Rio Grande do Sul, Brasil
- Fungos anemófilos na cidade de Porto Alegre, Rio Grande do Sul, Brasil